Also, in a study by Amini-Farsani et al. (2021), the role of miR-9 in regulating NF-κB and other inflammatory pathways in COVID-19 was highlighted, suggesting that targeting miRNAs could offer therapeutic benefits [20]. Here, NFKB1 is linked to COVID-19.